Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.49 |
| ▸ | SLC6A11 | P48066 | 4/20 | 0.47 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.41 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6522519 | 1.00 | KIF11 (0.49) | KIF11SLC6A11SLC6A1KCNH2CA4 | |
| SCHEMBL6891571 | 0.90 | KIF11 (0.48) | KIF11SLC6A11SLC6A1KCNH2CA4 | |
| SCHEMBL18803715 | 0.86 | KIF11 (0.52) | KIF11SLC6A11SLC6A1KCNH2CA4 | |
| SCHEMBL14879264 | 0.86 | KIF11 (0.52) | KIF11SLC6A11SLC6A1KCNH2CA4 | |
| SCHEMBL4012213 | 0.86 | KIF11 (0.63) | KIF11SLC6A1 | |
| SCHEMBL2985182 | 0.83 | KIF11 (0.49) | KIF11SLC6A11SLC6A1KCNH2CA4 | |
| SCHEMBL992028 | 0.83 | SLC6A11 (0.50) | KIF11SLC6A11SLC6A1KCNH2MEN1 | |
| SCHEMBL9215766 | 0.83 | KIF11 (0.49) | KIF11SLC6A11SLC6A1KCNH2CA4 | |
| SCHEMBL16197752 | 0.83 | KIF11 (0.50) | KIF11SLC6A11SLC6A1KCNH2CA4 | |
| SCHEMBL2490823 | 0.83 | KIF11 (0.73) | KIF11SLC6A11SLC6A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436138-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2013-05-07 | — | — | US | disclosed |
| US-8436138-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2013-05-07 | — | — | US | disclosed |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | MODPRO AB (SE) | 2012-03-01 | — | — | US | disclosed |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | MODPRO AB (SE) | 2012-03-01 | — | — | US | disclosed |
| US-8017347-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2011-09-13 | — | — | US | disclosed |
| US-8017347-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2011-09-13 | — | — | US | disclosed |
| US-20090305298-A1 | Binder for C-Reactive Protein | MODPRO AB (SE) | 2009-12-10 | — | — | US | disclosed |
| US-20090305298-A1 | Binder for C-Reactive Protein | MODPRO AB (SE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305298-A1 | Binder for C-Reactive Protein | C1QBP, RBP1, MYCBP | KIF11 4602/4885SLC6A11 4815/4885SLC6A1 4859/4885 |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | C1QBP, RBP1, MYCBP | KIF11 4602/4885SLC6A11 4815/4885SLC6A1 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.